Bio-Strategy has completed the acquisition of VWR’s lab supplies businesses in Australia and New Zealand, including Papua New Guinea and the Pacific Islands. As part of the transaction, Bio-Strategy also becomes VWR’s exclusive distributor in each of these locations.

Rangatira purchased a 70% shareholding in Bio-Strategy in June 2015. Bio-Strategy is a growing distributor of equipment and supplies to laboratories in research, medicine, manufacturing and industry throughout Australia and New Zealand. The business provides a comprehensive product range and complete service, including applications and technical support, to a broad range of private and public sector clients.

 

About Rangatira Limited

Rangatira is a Wellington-based investment company with shareholders’ funds of over $250 million. Established in 1937, the Company is 51 per cent owned by the JR McKenzie Trust with other community and charitable organisations owning another 15 per cent of the shares. The balance of the shares is owned by private investors. Rangatira’s mission is to increase both the capital value of its shares and the dividends paid to its shareholders by investing creatively and competitively.

Rangatira has built a portfolio of local and international investments across a wide range of sectors. The Company has pursued a policy of investment in small to medium-sized unlisted New Zealand companies, complemented by holdings in a range of publicly listed New Zealand and international companies. All investments have been made taking a long-term position in companies that are well founded and well managed with good growth potential.

Rangatira is strictly commercial in its investment approach and benchmarks its performance against the wider investment community.

Rangatira will continue to explore investment opportunities across a range of business sectors. We aim to add value to our unlisted investments by actively contributing at management and board level, recognising the need to combine high standards of governance with sound management and a clear focus on growth and profitability.

Rangatira’s shares are listed and traded on the Unlisted market (usx.co.nz).

 

Bio-Strategy has acquired VWR's lab supplies businesses in Australia and New Zealand.

 
+ Text Size -
Original generation time 0.4338 seconds.